News

Settlement Announcement: Cohen Cleary Data Incident Benefits

Settlement Announcement: Cohen Cleary Data Incident Benefits

Important Settlement Information for Affected Individuals

Announced by CPT Group, Inc.

In a significant development, CPT Group, Inc. has announced a proposed Settlement in a class action lawsuit referred to as Weekes v. Cohen Cleary, P.C., involving allegations of negligence against Cohen Cleary. It has been claimed that the firm failed to protect sensitive personal information leading to unauthorized access by a third party.

Overview of the Lawsuit

The core of this lawsuit revolves around accusations that Cohen Cleary was negligent towards their contractual and statutory obligations, affecting many individuals whose personal data was compromised during a data breach incident. The information potentially accessed includes names, addresses, Social Security numbers, and medical information. It is important to note that Cohen Cleary disputes all allegations of wrongdoing connected to this incident.

Who is Eligible for the Settlement?

The Settlement Class encompasses all individuals within the United States who had their private information compromised as a result of the identified data breach. This issue came to light due to an incident detected around September.

Settlement Benefits Overview

Cohen Cleary has committed to setting up a Settlement Fund totaling $150,000. Members of the Settlement Class who submit legitimate claims may receive reimbursement for documented losses directly related to the data breach, with amounts potentially reaching up to $5,000. Furthermore, claimants can also receive compensation for their time spent dealing with the breach, valued at $25 per hour, capped at four hours of work.

Additional Financial Details

After covering administrative expenses and legal fees, remaining amounts in the Settlement Fund will be distributed fairly among those who submit valid claims, ensuring that everyone impacted has the opportunity to receive a cash payment.

Filing a Claim: Step-by-Step

To determine eligibility for a financial payout, affected individuals should complete a Claim Form available online. It's crucial that all submissions are made either digitally or postmarked by the specified deadline.

Options Available to Claimants

Individuals have several pathways to consider regarding their participation in the settlement:

1. Do Nothing: Failing to take action means you will not receive any monetary compensation and will forfeit the right to pursue further legal action related to the claims involved in this settlement.

2. Exclude Yourself: Opting out will stop you from receiving any monetary benefits but allows you to pursue independent legal action if you choose. This requires a written request to be submitted by the said deadline.

3. Object to the Settlement: For those who are against the terms of the settlement, they can file a formal objection and may attend the Final Approval Hearing to present their concerns.

Looking Ahead: Next Steps

Following the data incident and subsequent lawsuit, the court is scheduled to hold a Final Approval Hearing to review and consider the settlement's approval. Participants have the right to attend this hearing, although hiring an attorney is not mandatory.

Further Information Resources

For more comprehensive information, including access to claim forms and additional legal documents, individuals are encouraged to visit the official site. A toll-free number is also available for inquiries and additional assistance, ensuring that all affected parties have adequate support in navigating the settlement process.

Frequently Asked Questions

What is the purpose of this Settlement?

The Settlement is designed to compensate those whose private information was compromised by a data breach involving Cohen Cleary.

Who qualifies as a member of the Settlement Class?

Any person in the United States whose sensitive information was potentially jeopardized due to the data breach.

What types of losses can be claimed?

Claimants can seek repayment for documented monetary losses up to $5,000 and reimbursement for time spent dealing with the breach.

How can I submit a claim?

Eligible individuals may submit an online claim form or post a claim form by the specified deadline to be considered.

Where can I find more information about this lawsuit?

More details, including claim forms and legal notices, can be accessed through the official settlement website or via the provided contact number.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ON1 Photo RAW 2027: New AI Tools, Better Processing

Updated Category News Views 50

Aiming for the Photography Crown ON1 isn't just tinkering on the fringes with their new Photo RAW 2027 release—they're diving headfirst into the deep end, aiming to outdo giants in the RAW processing world. I've seen my share of software updates that don't move the needle, but this one's packed to the gills with updates that photographers have been clamoring for. What's...

Continue Reading
China's Innovation Surge: Game Changer for Global Markets

Updated Category News Views 235

The Bold Shift in China's Economic Landscape Well, here's the scoop: China isn't just the world's assembly line anymore; it's gearing up to be a top-tier innovation hub. On the surface, might seem like another geopolitical spiel, but dig a little and you'll find it's a serious shake-up for global markets. We're talking about more than just products rolling out of...

Continue Reading
Jeep Wrangler Scrambler SRT: A Bold Off-Road Rebirth

Updated Category News Views 0

A New Legend in the Making Who would've thought we'd see the day when an SRT badge graced a Jeep Wrangler with such audacity? This ain't your typical Wrangler—they’ve slapped a bit of that CJ-8 throwback swagger, and given it the full-on SRT treatment. It's a mad machine, barreling into the future with one foot firmly planted in its legendary past. You ask any...

Continue Reading
Florida Homebuyers: Navigating Flood Zone Risks Smartly

Updated Category News Views 92

Florida Properties: The Buried Risk in Flood Zones If you’re dreaming of palm trees and sandy beaches, don't let flood zones turn that dream into a nightmare. It’s not all sunshine and rainbows when it comes to buying real estate in Florida, as it turns out—flood zones are lurking, and the devil's in the details. Understanding FEMA Flood Maps First off, these FEMA...

Continue Reading
ACA 2027 Enrollment: New Rules Aim to Simplify Coverage

Updated Category News Views 61

Navigating New Waters in 2027 ACA Open Enrollment If you're one of those folks who likes to wait until the last minute, the ACA's got a wake-up call for you this year. The 2027 open enrollment period started on November 1, 2026, with some pretty notable changes. The deadline for coverage beginning January 1, 2027, is December 15, so don't take a nap on this one, alright?...

Continue Reading
Beyon Expands Green Data Centres to Three Facilities

Updated Category News Views 37

Blazing Solar Trails in the Digital Landscape Lend an ear, folks, because Beyon's latest leap in the world of renewable energy isn't just another 'look how green we are' maneuver. Announced during Gateway Gulf 2026, this venture is all about serious numbers and even more serious energy chops. Beyon's on course to power a third data center entirely through solar energy,...

Continue Reading
Lazard Closes Deal with Campbell, Launches Lazard CL

Updated Category News Views 59

Talk about pulling a rabbit out of the hat! Lazard has just solidified its position in the private capital advisory game with the closure of its acquisition of Campbell Lutyens. They’re now rolling out Lazard CL, merging muscle across different strategies and diversifying those good ol’ revenue streams. It’s a peppy move from Lazard—not just for the cold hard...

Continue Reading
Xylitol: A Game Changer in Kids' Oral Care Battle

Updated Category News Views 91

Candy Challenges: Embracing Sweet Joys Responsibly Think you're done with Halloween? Nope. Welcome to the endless candy seasons when every festivity seems like an outlet for sugar overload—with parents caught between letting kids enjoy and guarding their teeth. Now, with Spry's recent push around xylitol, there's an option that might just mean an easier peace between...

Continue Reading
Military Medical Minds to Converge at MTEC Event in 2027

Updated Category News Views 72

Ever wonder where the cutting edge of military medicine takes shape? On February 16-17, 2027, Washington, DC becomes the epicenter for just that, as the Medical Technology Enterprise Consortium (MTEC) rolls out its 11th Annual Membership Meeting. A gathering of who's who in the world of military medical innovation, this event is like a high-stakes cocktail of science,...

Continue Reading
Sirolimus-Coated Balloon Shows Promise in TRANSFORM II

Updated Category News Views 96

Breaking Down the TRANSFORM II Trial Innovation never rests, folks, especially when it comes to treating coronary artery disease. Right on cue, the TRANSFORM II trial's results have hit the airwaves, marking a significant milestone with its implant-free MagicTouch Sirolimus-Coated Balloon (SCB) strategy. Getting the Lay of the Land This wasn't just some backyard...

Continue Reading

Top 5 Most Recently Viewed Articles

ATYR Stock Investors: Important Class Action Update

Updated Category News Views 139

Key Information for ATYR Pharma Shareholders ATYR Pharma, Inc. has recently faced significant challenges that have caught the attention of its shareholders. Investors who have purchased shares of ATYR during the specified class period are encouraged to stay informed about the ongoing legal developments. Engaging with The Gross Law Firm can provide shareholders with the...

Continue Reading
Zymeworks Stock Target Steady After Positive Trial Results

Updated Category News Views 89

Zymeworks Keeps Stock Rating Steady After ESMO 2024 Results Zymeworks Inc. (NASDAQ: ZYME) has maintained its stock rating and price target after revealing encouraging results from its recent cancer treatment clinical trials at a significant medical conference. The ratings firm H.C. Wainwright has reiterated a Neutral rating and set a price target of $10.00 per share...

Continue Reading
Exploring New Opportunities in Convertible Bonds with BMAX ETF

Updated Category News Views 253

Introduction to the New ETF A recently introduced exchange-traded fund (ETF), known as the REX Bitcoin Corporate Treasury Convertible Bond ETF (BMAX), is gaining attention for its focus on convertible bonds from companies that have Bitcoin included in their financial strategies. This ETF began trading recently and represents a growing trend in the investment landscape....

Continue Reading
iBio Secures Strategic Investments to Propel Biotech Advancements

Updated Category News Views 140

iBio's Strategic Investment Announcement iBio, Inc. (NYSE: IBIO), a pioneer in AI-driven antibody immunotherapies, has made an impactful stride in its mission, announcing the successful closure of a private investment offering totaling over $650,000 from its Board of Directors and corporate officers. This investment is a significant vote of confidence in iBio's strategy...

Continue Reading
Simulmedia Welcomes Jonathan Steuer as Chief Scientist

Updated Category News Views 111

Simulmedia Appoints Jonathan Steuer as Chief Scientist Simulmedia, a leader in cross-channel TV and connected TV (CTV) advertising, is thrilled to announce a significant addition to its executive team. Jonathan Steuer, a prominent figure in media research and data science, has been appointed as the Chief Scientist. With a remarkable background as a scientist and...

Continue Reading